Lymphoma

Disease State Hub

Q&As

Hodgkin Lymphoma

Kirsten K. Ness, PT, PhD, on Ensuring Adequate Fitness in Childhood Hodgkin Lymphoma Survivors

11/14/2018

Consultant360 spoke with Kirsten K. Ness, PT, PhD, of St Jude Children’s Research Hospital, whose study found that survivors of childhood-onset Hodgkin lymphoma have an increased risk of impaired physical...

11/14/2018

Research Summaries

FDA Alert

FDA Grants Accelerated Approval for First CAR-T Cell Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

04/22/2024

Anthony Calabro, MA

The FDA previously approved lisocabtagene maraleucel as a second-line treatment option for adult patients with large B-cell lymphoma in June 2022.

04/22/2024

FDA ALERT

FDA Approves Pirtobrutinib For Treating Adults With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

01/26/2024

Anthony Calabro, MA

The FDA approved pirtobrutinib for adults with either chronic lymphocytic leukemia or small lymphocytic lymphoma who have received at least two prior lines of therapy.

01/26/2024

Oncology

Protein-Energy Malnutrition Increases the Risk of Death in Patients With DLBCL Undergoing Chemotherapy

06/27/2022

Researchers examined the impact of protein-energy malnutrition on the risk of death in patients with diffuse large B-cell lymphoma who are undergoing chemotherapy.

06/27/2022

Health care disparities

Racial Disparities in Overall Survival of Diffuse Large B-cell Lymphoma

06/20/2022

Authors presented research on racial differences of overall survival outcomes among individuals with diffuse large B-cell lymphoma at ASCO 2022.

06/20/2022

Lymphoma

IBD Treatment Could Increase Risk of Lymphoma

11/08/2017

The risk of lymphoma has been reported to be higher among patients with IBD receiving thiopurines. In a recent study, researchers sought to further investigate this risk among patients with IBD with various...

11/08/2017

October 2024

Current Issue

October 2024

Volume 64

Issue 9